BIOMARKERS FOR SEPSIS

摘要

The present invention relates to the identification and use of biomolecules (analytes) or biomarkers related to sepsis. More specifically, the invention relates to the distinction of SIRS and sepsis based on a change in analyte or biomolecule concentration in a test sample of a subject diagnosed with or suspected of suffering from SIRS or sepsis. Moreover, the invention relates to, based a change in analyte or biomolecule concentration is a test sample, assigning a specific sepsis state or condition in terms of sepsis, severe sepsis and sepsis shock; as well as to assigning the expected outcome of the sepsis condition.